Back

Antithrombotic strategies in elderly patients with atrial fibrillation revascularized with drug-eluting stents: PACO-PCI (EPIC-15) registry

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Interventional Cardiology ePosters Adjunctive Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Jose Maria De La Torre Hernandez

Marquis of Valdecilla University Hospital, Santander (Spain)

133 More presentations in this session

Presentation thumbnail
Vitamin D deficiency predicts the no-reflow phenomenon in STEMI patients undergoing primary percutaneous coronary intervention.
Doctor M. Verdoia (Biella, IT)
Abstract Slides
Presentation thumbnail
Effectiveness and prognostic value of intravscular imaging in patients with left main coronary artery stenosis and heart failure
Associate Professor D. Maximkin (Moscow, RU)
Abstract Slides
Presentation thumbnail
Late outcomes of percutaneous coronary interventions (PCI) and subsequent life-quality in patients younger 40 years of age
Professor F. Abdullayev (Baku, AZ)
Abstract Slides
Presentation thumbnail
Rapid pacing is an independent predictor for high implantation depth using self-expandable devices in TAVR
Assistant Professor V. Veulemans (Duesseldorf, DE)
Abstract Slides
Presentation thumbnail
Influence of the speed of deflation of the stent delivery system in the myocardial blush and st-segment resolution in primary angioplasty: a randomized study
Doctor I. Lozano Martinez-Luengas (Gijon, ES)
Abstract Slides

Access the full session

Session thumbnail
Interventional Cardiology ePosters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Oral anticoagulation monotherapy versus combination antithrombotic therapy in patients with AF and PCI with a drug-eluting stent implantation: a systematic review and meta-analysis
23 April 2026
thumbnail
Congress Presentation
Low-dose edoxaban in patients 80 years and older with atrial fibrillation and dose-reduction criteria: randomized analysis between edoxaban 15 mg and 30 mg
1 September 2025
thumbnail
Congress Presentation
Percutaneous coronary intervention in the age of frailty
2 September 2019
thumbnail
Congress Presentation
Oral anticoagulants in older patients with atrial fibrillation: insights from a nationwide study
4 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources